Kayzoni (Crizotinib)

Kayzoni (Crizotinib）is an anticancer medicine containing the active substance crizotinib used to treat adults with a type of lung cancer called non-small cell lung cancer, that presents with a specific rearrangement or defect in either a gene called anaplastic lymphoma kinase (ALK) or a gene called ROS1.

Kayzoni (Crizotinib) can be prescribed to you for the initial treatment if your disease is at an advanced stage of lung cancer. Kayzoni (Crizotinib) can be prescribed to you if your disease is at an advanced stage and previous treatment has

not helped to stop your disease.

Kayzoni (Crizotinib) may slow or stop the growth of lung cancer. It may help shrink tumours.